ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

This multi-target blood test "offers the potential for improved patient outcomes through earlier HCC detection," John said ...

Fatty liver disease is becoming increasingly common, affecting millions around the world. The underlying cause of this is too ...

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk in patients with compensated MASH cirrhosis Rezdiffra ...

Recognizing early liver disease signs is crucial as many conditions develop silently. Persistent fatigue, jaundice, abdominal swelling, confusion, fre ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

Given just how much lifestyle disorders or non-communicable diseases are on the rise these days, it is quite likely that you would have taken a liver function test (LFT) and then consulted the doctor ...

At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune ...

For the first time, we have tools capable of perceiving the world, interpreting it and autonomously taking steps to improve ...